biomarker for response to IFNbeta

A forum to discuss research on the origins of MS and its development.
Post Reply
User avatar
Family Elder
Posts: 1554
Joined: Wed Dec 02, 2009 3:00 pm

biomarker for response to IFNbeta

Post by frodo » Wed Aug 12, 2020 10:58 am

IFI35 as a biomolecular marker of neuroinflammation and treatment response in multiple sclerosis ... 0520309851


• No biomarker is available for predicting treatment response and neuroinflammation in Multiple Sclerosis.
• IFI35 increases from the untreated to IFNbeta-1a treated MS patients, compared to HCs.
• IFI35 evidences predictive characteristics respect to lesion burden, WMF and formulation type of IFN.
• IFI35 discriminates the responder to IFN therapy from the non-responder patient.
• IFI35 biological pattern highlights a predictive profile drugs monitoring and innate immunity-dependent neuroinflammation.

Post Reply
  • Similar Topics
    Last post

Return to “MS Etiology and Pathogenesis”